Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec AG | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Evotec AG

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Joern Aldag will resign from his position as president & chief executive officer of Evotec, effective December 31, 2008. Dr. Mario Polywka, chief operating officer, and Dr. Klaus Maleck, chief financial officer, will jointly lead the Company until a permanent successor is announced.

Dr. Flemming Ornskov, Evotec’s chairman, said, “During his 11-year tenure, Joern Aldag played a pivotal role in the transformation of Evotec from a technology provider to an integrated, CNS-focused biopharmaceutical company. Today the company has a very strong financial position and a deep preclinical and clinical pipeline of CNS drug candidates that provide a strong basis for future success. On behalf of the Evotec board, I would like to thank Joern Aldag for his effective and very successful leadership of the Company and we wish him ongoing success for his future endeavors.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters